At the time of writing, Biohaven Ltd [BHVN] stock is trading at $41.43, down -0.86%. An important factor to consider is whether the stock is rising or falling in short-term value. The BHVN shares have gain 7.81% over the last week, with a monthly amount glided 14.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on February 11, 2025, when Deutsche Bank initiated its Buy rating and assigned the stock a price target of $65. Previously, Jefferies started tracking the stock with Buy rating on September 16, 2024, and set its price target to $57. On September 04, 2024, Bernstein initiated with a Outperform rating and assigned a price target of $55 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $58 on July 24, 2024. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $62 as its price target on February 16, 2024. UBS started tracking with a Buy rating for this stock on February 06, 2024, and assigned it a price target of $59. In a note dated December 22, 2023, H.C. Wainwright initiated an Buy rating and provided a target price of $50 on this stock.
For the past year, the stock price of Biohaven Ltd fluctuated between $26.80 and $62.21. Currently, Wall Street analysts expect the stock to reach $59.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $41.43 at the most recent close of the market. An investor can expect a potential return of 43.62% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.58, Equity is -2.25 and Total Capital is -2.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.83 points at the first support level, and at 40.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.43, and for the 2nd resistance point, it is at 43.42.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 2.89. On the other hand, the Quick Ratio is 2.89, and the Cash Ratio is 0.55.
Transactions by insiders
Recent insider trading involved CHILDS JOHN W, Director, that happened on Dec 30 ’24 when 29000.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Oct 02 ’24 to buy 21052.0 shares. Meanwhile, Chief Executive Officer Coric Vlad bought 21052.0 shares on Oct 02 ’24.
